
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (31): 3932-3941.DOI: 10.12114/j.issn.1007-9572.2024.0646
• Original Research • Previous Articles Next Articles
Received:2024-12-09
Revised:2025-05-16
Published:2025-11-05
Online:2025-09-23
Contact:
WANG Peng, TAO Liyuan
通讯作者:
王鹏, 陶立元
作者简介:作者贡献:
廖姣姣、王照宇、陶立元提出研究思路,设计研究方案;廖姣姣、王照宇、李兆基负责研究数据的收集和整理;廖姣姣、王照宇、赵威负责数据的统计分析和研究结果的解释及可视化;廖姣姣负责论文起草;詹思延、王鹏、陶立元负责论文的修订;王鹏、陶立元对文章整体负责,监督管理。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0646
| 指标 | 男(n=2 487) | 女(n=3 254) | ||||||
|---|---|---|---|---|---|---|---|---|
| 无颈动脉内中膜增厚(n=2 094) | 颈动脉内中膜增厚(n=393) | Z(χ2)值 | P值 | 无颈动脉内中膜增厚(n=2 924) | 颈动脉内中膜增厚(n=330) | Z(χ2)值 | P值 | |
| 随访时间[M(Q1,Q3),年] | 3.26(1.83,5.09) | 3.99(2.11,6.07) | -3.57 | <0.001 | 3.79(1.98,6.22) | 4.13(2.05,7.19) | -3.74 | <0.001 |
| 年龄[M(Q1,Q3),岁] | 32.40(27.99,39.05) | 41.71(35.21,48.12) | -15.56 | <0.001 | 34.61(29.37,40.55) | 43.75(39.18,48.25) | -16.76 | <0.001 |
| BMI[M(Q1,Q3),kg/m2] | 24.30(22.30,26.52) | 25.05(23.01,27.00) | -3.70 | <0.001 | 21.50(19.83,23.39) | 22.39(20.90,24.40) | -5.95 | <0.001 |
| SBP[M(Q1,Q3),mmHg] | 122(114,131) | 125(114,133) | -2.64 | 0.008 | 112(104,121) | 118(109,128) | -7.38 | <0.001 |
| DBP[M(Q1,Q3),mmHg] | 74(68,81) | 77(71,84) | -4.96 | <0.001 | 69(63,75) | 72(66,79) | -5.58 | <0.001 |
| TC[M(Q1,Q3),mg/dL] | 172.85(155.45,191.80) | 178.27(160.48,197.22) | -3.55 | 0.001 | 172.85(154.29,191.90) | 185.23(165.22,204.85) | -6.50 | <0.001 |
| TG[M(Q1,Q3),mg/dL] | 105.40(78.83,140.83) | 114.26(88.57,152.34) | -3.85 | <0.001 | 78.83(60.23,104.51) | 95.66(71.74,119.35) | -6.94 | <0.001 |
| LDL-C[M(Q1,Q3),mg/dL] | 107.89(92.42,124.52) | 114.46(96.29,129.93) | -3.87 | <0.001 | 99.38(84.69,115.24) | 110.79(92.61,126.35) | -6.77 | <0.001 |
| HDL-C[M(Q1,Q3),mg/dL] | 45.24(40.60,51.43) | 45.24(40.22,51.43) | 0.92 | 0.356 | 55.30(48.34,63.03) | 53.36(47.27,61.87) | 1.86 | 0.063 |
| nHDL-C[M(Q1,Q3),mg/dL] | 126.45(109.44,144.24) | 133.41(112.92,150.04) | -3.88 | <0.001 | 115.62(99.77,134.57) | 129.54(109.82,146.56) | -7.70 | <0.001 |
| 高血压[例(%)] | 252(12.0) | 64(16.3) | 5.01a | 0.025 | 123(4.2) | 25(7.6) | 7.00a | 0.008 |
| 高尿酸血症[例(%)] | 624(29.8) | 117(29.8) | <0.001a | 1.000 | 36(1.2) | 3(0.9) | 0.06a | 0.808 |
Table 1 Basic characteristics of the study participants
| 指标 | 男(n=2 487) | 女(n=3 254) | ||||||
|---|---|---|---|---|---|---|---|---|
| 无颈动脉内中膜增厚(n=2 094) | 颈动脉内中膜增厚(n=393) | Z(χ2)值 | P值 | 无颈动脉内中膜增厚(n=2 924) | 颈动脉内中膜增厚(n=330) | Z(χ2)值 | P值 | |
| 随访时间[M(Q1,Q3),年] | 3.26(1.83,5.09) | 3.99(2.11,6.07) | -3.57 | <0.001 | 3.79(1.98,6.22) | 4.13(2.05,7.19) | -3.74 | <0.001 |
| 年龄[M(Q1,Q3),岁] | 32.40(27.99,39.05) | 41.71(35.21,48.12) | -15.56 | <0.001 | 34.61(29.37,40.55) | 43.75(39.18,48.25) | -16.76 | <0.001 |
| BMI[M(Q1,Q3),kg/m2] | 24.30(22.30,26.52) | 25.05(23.01,27.00) | -3.70 | <0.001 | 21.50(19.83,23.39) | 22.39(20.90,24.40) | -5.95 | <0.001 |
| SBP[M(Q1,Q3),mmHg] | 122(114,131) | 125(114,133) | -2.64 | 0.008 | 112(104,121) | 118(109,128) | -7.38 | <0.001 |
| DBP[M(Q1,Q3),mmHg] | 74(68,81) | 77(71,84) | -4.96 | <0.001 | 69(63,75) | 72(66,79) | -5.58 | <0.001 |
| TC[M(Q1,Q3),mg/dL] | 172.85(155.45,191.80) | 178.27(160.48,197.22) | -3.55 | 0.001 | 172.85(154.29,191.90) | 185.23(165.22,204.85) | -6.50 | <0.001 |
| TG[M(Q1,Q3),mg/dL] | 105.40(78.83,140.83) | 114.26(88.57,152.34) | -3.85 | <0.001 | 78.83(60.23,104.51) | 95.66(71.74,119.35) | -6.94 | <0.001 |
| LDL-C[M(Q1,Q3),mg/dL] | 107.89(92.42,124.52) | 114.46(96.29,129.93) | -3.87 | <0.001 | 99.38(84.69,115.24) | 110.79(92.61,126.35) | -6.77 | <0.001 |
| HDL-C[M(Q1,Q3),mg/dL] | 45.24(40.60,51.43) | 45.24(40.22,51.43) | 0.92 | 0.356 | 55.30(48.34,63.03) | 53.36(47.27,61.87) | 1.86 | 0.063 |
| nHDL-C[M(Q1,Q3),mg/dL] | 126.45(109.44,144.24) | 133.41(112.92,150.04) | -3.88 | <0.001 | 115.62(99.77,134.57) | 129.54(109.82,146.56) | -7.70 | <0.001 |
| 高血压[例(%)] | 252(12.0) | 64(16.3) | 5.01a | 0.025 | 123(4.2) | 25(7.6) | 7.00a | 0.008 |
| 高尿酸血症[例(%)] | 624(29.8) | 117(29.8) | <0.001a | 1.000 | 36(1.2) | 3(0.9) | 0.06a | 0.808 |
| 潜类别个数(个) | 最大对数似然估计值 | AIC | BIC | SABIC | 熵值 | Score Test P值 | 人数[例(%)] | |||
|---|---|---|---|---|---|---|---|---|---|---|
| 类别1 | 类别2 | 类别3 | 类别4 | |||||||
| 1 | -44 963.82 | 89 957.64 | 90 044.92 | 89 997.27 | 1.000 0 | 0 | 2 487(100.00) | |||
| 2 | -44 923.37 | 89 888.75 | 90 010.94 | 89 944.22 | 0.484 3 | 0.050 5 | 2 123(85.36) | 364(14.64) | ||
| 3 | -44 899.70 | 89 853.39 | 90 010.50 | 89 924.71 | 0.607 1 | 0.207 9 | 2 084(83.80) | 27(1.09) | 376(15.12) | |
| 4 | -44 891.23 | 89 848.46 | 90 040.48 | 89 935.64 | 0.561 6 | 0.919 7 | 274(11.02) | 37(1.49) | 82(3.30) | 2 094(84.20) |
Table 2 Results of determining the optimal number of groups for the model in male subjects
| 潜类别个数(个) | 最大对数似然估计值 | AIC | BIC | SABIC | 熵值 | Score Test P值 | 人数[例(%)] | |||
|---|---|---|---|---|---|---|---|---|---|---|
| 类别1 | 类别2 | 类别3 | 类别4 | |||||||
| 1 | -44 963.82 | 89 957.64 | 90 044.92 | 89 997.27 | 1.000 0 | 0 | 2 487(100.00) | |||
| 2 | -44 923.37 | 89 888.75 | 90 010.94 | 89 944.22 | 0.484 3 | 0.050 5 | 2 123(85.36) | 364(14.64) | ||
| 3 | -44 899.70 | 89 853.39 | 90 010.50 | 89 924.71 | 0.607 1 | 0.207 9 | 2 084(83.80) | 27(1.09) | 376(15.12) | |
| 4 | -44 891.23 | 89 848.46 | 90 040.48 | 89 935.64 | 0.561 6 | 0.919 7 | 274(11.02) | 37(1.49) | 82(3.30) | 2 094(84.20) |
| 潜类别个数(个) | 最大对数似然估计值 | AIC | BIC | SABIC | 熵值 | Score Test P值 | 人数[例(%)] | |||
|---|---|---|---|---|---|---|---|---|---|---|
| 类别1 | 类别2 | 类别3 | 类别4 | |||||||
| 1 | -61 939.82 | 123 907.64 | 123 992.87 | 123 948.39 | 1.000 0 | 0 | 3 254(100.00) | |||
| 2 | -61 901.56 | 123 843.12 | 123 964.87 | 123 901.32 | 0.652 3 | 0.008 8 | 3 000(92.19) | 254(7.81) | ||
| 3 | -61 878.90 | 123 809.81 | 123 968.08 | 123 885.47 | 0.694 6 | 0.010 1 | 2 978(91.36) | 23(0.86) | 253(7.78) | |
| 4 | -61 868.66 | 123 801.32 | 123 996.12 | 123 894.44 | 0.658 5 | 0.267 8 | 3 029(93.09) | 41(1.26) | 149(4.58) | 35(1.08) |
Table 3 Results of determining the optimal number of groups for the model in female subjects
| 潜类别个数(个) | 最大对数似然估计值 | AIC | BIC | SABIC | 熵值 | Score Test P值 | 人数[例(%)] | |||
|---|---|---|---|---|---|---|---|---|---|---|
| 类别1 | 类别2 | 类别3 | 类别4 | |||||||
| 1 | -61 939.82 | 123 907.64 | 123 992.87 | 123 948.39 | 1.000 0 | 0 | 3 254(100.00) | |||
| 2 | -61 901.56 | 123 843.12 | 123 964.87 | 123 901.32 | 0.652 3 | 0.008 8 | 3 000(92.19) | 254(7.81) | ||
| 3 | -61 878.90 | 123 809.81 | 123 968.08 | 123 885.47 | 0.694 6 | 0.010 1 | 2 978(91.36) | 23(0.86) | 253(7.78) | |
| 4 | -61 868.66 | 123 801.32 | 123 996.12 | 123 894.44 | 0.658 5 | 0.267 8 | 3 029(93.09) | 41(1.26) | 149(4.58) | 35(1.08) |
| JLCM分类 | HR(95%CI) | P值 |
|---|---|---|
| 男 | ||
| 类别1(低水平稳定组) | 1.00 | |
| 类别3(缓慢升高组) | 10.51(7.90~13.98) | <0.001 |
| 类别2(快速升高组) | 23.25(10.40~51.98) | <0.001 |
| 女 | ||
| 类别1(低水平稳定组) | 1.00 | |
| 类别2(低水平稳定-升高组) | 3.69(2.27~5.99) | <0.001 |
| 类别3(中等水平稳定组) | 15.48(10.56~22.70) | <0.001 |
| 类别4(快速升高组) | 13.93(5.44~35.69) | <0.001 |
Table 4 Hazard ratios for each latent class of non-HDL-C in male and female populations
| JLCM分类 | HR(95%CI) | P值 |
|---|---|---|
| 男 | ||
| 类别1(低水平稳定组) | 1.00 | |
| 类别3(缓慢升高组) | 10.51(7.90~13.98) | <0.001 |
| 类别2(快速升高组) | 23.25(10.40~51.98) | <0.001 |
| 女 | ||
| 类别1(低水平稳定组) | 1.00 | |
| 类别2(低水平稳定-升高组) | 3.69(2.27~5.99) | <0.001 |
| 类别3(中等水平稳定组) | 15.48(10.56~22.70) | <0.001 |
| 类别4(快速升高组) | 13.93(5.44~35.69) | <0.001 |
| [1] |
|
| [2] |
国家心血管病中心,中国心血管健康与疾病报告编写组,胡盛寿. 中国心血管健康与疾病报告2023概要[J]. 中国循环杂志,2024,39(7):625-660.
|
| [3] |
|
| [4] |
|
| [5] |
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国头颈部动脉粥样硬化诊治共识[J]. 中华神经科杂志,2017,50(8):572-578.
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
中国血脂管理指南修订联合专家委员会. 中国血脂管理指南(2023年)[J]. 中国循环杂志,2023,38(3):237-271.
|
| [16] |
中国高血压防治指南修订委员会,高血压联盟(中国),中国医疗保健国际交流促进会高血压病学分会,等. 中国高血压防治指南(2024年修订版)[J]. 中华高血压杂志(中英文),2024,32(7):603-700.
|
| [17] |
中华医学会内分泌学分会. 中国高尿酸血症与痛风诊疗指南(2019)[J]. 中华内分泌代谢杂志,2020,36(1):1-13.
|
| [18] |
秦瑶,韩红娟,刘龙,等. 联合潜在类别模型在轻度认知障碍向认知正常逆转研究中的应用[J]. 中国卫生统计,2023,40(6):836-840.
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
National Clinical Guideline Centre. Lipid modification-CVD prevention[EB/OL].(2024-09-01)[2024-11-23].
|
| [24] |
|
| [1] | HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian. Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2026, 29(21): 2950-2958. |
| [2] | LIU Shuai, YUAN Shizhao, LIU Yan, JIA Shuoxian, ZHAO Yan, WANG Ziyi, ZHOU Chunhua, YU Jing. Evaluation of the Efficacy, Safetyand Economy of Different Amphotericin B Formulationsin Invasive Fungal Disease: a Retrospective Cohort Study [J]. Chinese General Practice, 2026, 29(21): 2967-2974. |
| [3] | CHAI Zhihao, ZHANG Weisen, LUO Jiaoling, ZHU Feng, ZHU Tong, JIN Yali, PAN Jing, LU Yingjun, JIANG Chaoqiang. The Mediation Effect of Socioeconomic Status in Childhood Parental Literacy and Cognitive Function in Middle-aged and Older People: Based on Guangzhou Biobank Cohort Study [J]. Chinese General Practice, 2026, 29(21): 2959-2966. |
| [4] | REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan. Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients [J]. Chinese General Practice, 2026, 29(20): 2836-2845. |
| [5] | LIU Daiyue, LIU Xincan, LAN Zhenzhen. Research Progress on Postprandial Hyperlipidemia and Its Therapeutic Approaches [J]. Chinese General Practice, 2026, 29(18): 2546-2553. |
| [6] | JIAN Yingchun, ZENG Yongqin, ZHANG Haiping, WANG Zhengdi, AN Ke, YAN Rui. Recent Advances in Mitochondrial Dysfunction in Chronic Metabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2577-2584. |
| [7] | QIU Xinyu, ZHAO Qian, CHEN Yufei, JIAMULE· Maimaitiyiming, HAN Congcong, AIKEDAN· Aierken, LI Xiaomei, YANG Yining. Weight Status and Metabolic Characteristics on the Longitudinal Trajectory of Systolic Blood Pressure: a Cohort Study [J]. Chinese General Practice, 2026, 29(15): 2006-2013. |
| [8] | LIU Xiang, CHEN Hong, CUI Rui, GUO Zhichao, LI Panpan, CAO Zilong, JI Yiqing, YU Wenya. Consistencies and Differences in Early Childhood Development Characteristics in Megacities: a Retrospective Cohort Study [J]. Chinese General Practice, 2026, 29(11): 1411-1421. |
| [9] | LI Qiuchun, SU Ping, PANG Jinhong, CHEN Qiaoqiao, ZHAO Yingying, HE Ruiyan, WANG Yue, CHEN Xueyu, QIAO Junpeng, CHI Weiwei. Association of Triglyceride Glucose Index with Cardiovascular Disease in Cardiovascular-Kidney-Metabolic Syndrome Stage 0-3 Population: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(09): 1129-1136. |
| [10] | SUN Qinyu, DENG Yifan, YANG Tianxiao, FANG Zhen, JI Jun, HE Shenghu, ZHANG Jing. Clinical Study of HbA1c/ApoA-1, TyG-BMI and Their Combination to Predict the Severity of Coronary Artery Calcification [J]. Chinese General Practice, 2026, 29(09): 1137-1145. |
| [11] | ZHAO Qianqian, ZHANG Mei, LI Yanying, ZHANG Yanhong, YAN Wenhua, PAN Hui, BAN Bo. Clinical Characteristics of Growth Hormone Deficiency and Analysis of the Efficacy of Recombinant Human Growth Hormone: a Ten-year Longitudinal Cohort Study [J]. Chinese General Practice, 2026, 29(06): 733-740. |
| [12] | LU Yanqiu, WU Yuntao, LIU Shaopeng, LIN Haiying, DENG Huiyou, WU Ying, HUANG Zhe, YANG Peng, WU Shouling, LI Yun. Effect of Blood Pressure Trajectory on Cardiovascular Disease in Population with High-normal Blood Pressure: a Study Based on the Kailuan Cohort [J]. Chinese General Practice, 2026, 29(03): 299-310. |
| [13] | DIJI Zhuoma, ZOU Yanqiu, ZHENG Dixin, HU Mengjie, LIU Xiaoxue, JIANG Xia, FAN Mengyu, LI Jiayuan. Association of Social Isolation, Loneliness, with Incidence Risk of Cardiovascular Diseases: a Prospective Chinese Study [J]. Chinese General Practice, 2026, 29(01): 122-128. |
| [14] | LIU Ruiyue, YANG Xuemei, ZHAO Naihui, WEN Xinran, CAI Xi, LIANG Yajing, MA Jiajia, WU Shouling, CUI Liufu. The Impact of the Ratio of High-sensitivity C-reactive Protein to Albumin on Incident Cardiovascular Disease in Different Age Groups: a Cohort Study [J]. Chinese General Practice, 2025, 28(36): 4566-4577. |
| [15] | WANG Biyou, GAO Ying, YOU Junfang, LIU Li, ZHANG Qing, SU Haiyan. Canonical Correlation Analysis of Lipid Ratios and Inflammatory Markers in Individuals at Risk of Cardiovascular Disease [J]. Chinese General Practice, 2025, 28(33): 4132-4139. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||